Stephen Uden - Feb 7, 2022 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Chief Operating Officer & Chief Scientific Officer
Signature
/s/ Michael Greco, Attorney-in-Fact
Stock symbol
RLYB
Transactions as of
Feb 7, 2022
Transactions value $
$0
Form type
4
Date filed
2/9/2022, 06:39 PM
Previous filing
Jul 29, 2021
Next filing
Feb 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +62K $0.00 62K Feb 7, 2022 Common Stock 62K $15.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 7, 2026.

Remarks:

Chief Operating Officer & Chief Scientific Officer